Shareholding disclosure
JPMorgan Chase & Co
Declared position
4.697%
Threshold
Crossed upwards
Timeline
Published
07.05.2014
Transaction
29.04.2014
Voting rights breakdown
Notice details
Notification ID
TAE5600027
Beneficial owner
JPMorgan Chase & Co
Declared address
Jpmorgan chase &co., Ny10017 new york
change in company registered capital Relationship between JPMorgan Chase & Co. and the subsidiaries holding shares in Newron Pharmaceuticals SpA at 29 April 2014 1. JPMorgan Asset Management (UK) Limited JPMorgan Chase & Co. JPMorgan Asset Management Ho1dings Inc. (100%) JPMorgan Asset Management Intemationa1 Limited (100%) JPMorgan Asset Management Holdings (UK) Limited (l00%) JPMorgan Asset Management (UK) Limited (1 00%) Business Addresses JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017,United States JPMorgan Asset Management Ho1dings Inc., 270 Park Avenue,New York, NY 10017, United States JPMorgan Asset Management International Limited, Finsbury Dials, 20 Finsbury Street, London EC2Y 9AQ, United Kingdom JPMorgan Asset Management Holdings (UK) Limited, Finsbury Dia1s, 20 Finsbury Street, London EC2Y 9AQ, United Kingdom JPMorgan Asset Management (UK) Limited, Finsbury Dials, 20 Finsbury Street, London EC2Y 9AQ, United Kingdom Registered Addresses JPMorgan Chase & Co., c/o The Corporation Trust Company, 1209 Orange Street, Wilmington, Delaware, DE 19081, United States JPMorgan Asset Management Holdings Inc., c/o The Corporation Trust Company, 1209 Orange Street, Wilmington,Delaware, DE 19081, United States JPMorgan Asset Management International Limited, 25 Bank Street, Canary Wharf, London E145JP, United Kingdom JPMorgan Asset Management Holdings (UK) Limited, 25 Bank Street, Canary Wharf, London E145JP, United Kingdom JPMorgan Asset Management (UK) Limited, 25 Bank Street,Canary Wharf, London E145JP, United Kingdom
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan